Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
28.99
+0.03 (0.10%)
Nov 26, 2025, 4:00 PM EST - Market closed
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of $4.23 billion as of November 28, 2025. Its market cap has increased by 96.81% in one year.
Market Cap
4.23B
Enterprise Value
4.11B
1-Year Change
96.81%
Ranking
Category
Stock Price
$28.99
Market Cap Chart
Since the IPO on May 28, 2021, Centessa Pharmaceuticals's market cap has increased from $1.75B to $4.23B, an increase of 142.11%. That is a compound annual growth rate of 21.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 4.23B | 91.69% |
| Dec 31, 2024 | 2.21B | 184.18% |
| Dec 29, 2023 | 777.13M | 165.01% |
| Dec 30, 2022 | 293.25M | -71.03% |
| Dec 31, 2021 | 1.01B | -42.11% |
| May 28, 2021 | 1.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |